0001213900-24-044315.txt : 20240516
0001213900-24-044315.hdr.sgml : 20240516
20240516161052
ACCESSION NUMBER: 0001213900-24-044315
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240514
FILED AS OF DATE: 20240516
DATE AS OF CHANGE: 20240516
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Tesi Raymond Joseph
CENTRAL INDEX KEY: 0001767280
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38793
FILM NUMBER: 24955644
MAIL ADDRESS:
STREET 1: 476 MASSACHUSETTS AVE, UNIT 2
CITY: BOSTON
STATE: MA
ZIP: 02118
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Inmune Bio, Inc.
CENTRAL INDEX KEY: 0001711754
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 475205835
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 225 NE MIZNER BLVD, SUITE 640
CITY: BOCA RATON
STATE: FL
ZIP: 33432
BUSINESS PHONE: 8589643720
MAIL ADDRESS:
STREET 1: 225 NE MIZNER BLVD, SUITE 640
CITY: BOCA RATON
STATE: FL
ZIP: 33432
4
1
ownership.xml
X0508
4
2024-05-14
0
0001711754
Inmune Bio, Inc.
INMB
0001767280
Tesi Raymond Joseph
C/O INMUNE BIO INC.
225 NE MIZNER BLVD., SUITE 640
BOCA RATON,
FL
33432
1
1
1
0
President and CEO
0
Option (right to buy)
9.92
2024-05-14
4
A
0
160000
0
A
2034-05-13
Common Stock
160000
160000
D
Granted pursuant to the 2021 Stock Incentive Plan. One fourth (1/4) of the option will vest 12 months from the grant date and thereafter the remaining unvested option will become vested and exercisable on a monthly basis over three (3) years (1/36 per month) until the option is 100% vested which shall occur on the four-year anniversary of the grant date.
/s/ Raymond Joseph Tesi
2024-05-16